Skip to content

Written by Sarah Collins · Every article cited · Reviewed on a schedule

How we source
PCOSguides
All topics

1000 articles planned across 8 sections. Each one carries a minimum of three primary sources.

PCOS IVF Success Rate by Age: Why the Number Depends on What You Divide By

10 min read

Written by Sarah CollinsChecked against the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOSLast reviewed Published

A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.

The short answer

There is no single “PCOS IVF success rate” — a 2013 SART registry analysis found PCOS patients had a higher per-cycle live birth rate (34.8% vs. 29.1%), but which number a clinic quotes depends on whether it counts per cycle started, per retrieval, or per embryo transferred, and those can differ by 10 to 20 percentage points for the identical patient.

What Does “Success Rate” Actually Mean, and Why Does It Change With the Denominator?

The same age band produces different published numbers depending on what sits on the bottom of the fraction. The UK’s national fertility regulator reports outcomes per embryo transferred; the largest US clinic registry reports outcomes per intended egg retrieval, sometimes counted through only the first transfer and sometimes counted cumulatively through every frozen transfer that follows. None of these is “the” success rate — each answers a slightly different question, and a clinic quoting the most flattering one is not necessarily quoting the wrong one, just the one that makes the denominator invisible.

Table 1 — IVF birth rate by age, per embryo transferred (Human Fertilisation and Embryology Authority, England and Wales, 2021 preliminary data, own eggs, fresh cycles).
Age bandBirth rate per embryo transferred
18–3433%
35–3725%
38–3917%
40–4210%
43–504%

Table 1 is national, not PCOS-specific — HFEA does not publish a separate PCOS breakdown, and no credible source should claim to speak for HFEA data it does not report (HFEA, 2021 preliminary figures). What it establishes is the baseline age-related decline every subsequent PCOS-specific number in this article sits on top of, and it establishes the denominator: “per embryo transferred” excludes every cycle that was cancelled before retrieval, every retrieval that produced no embryo to transfer, and every cycle where embryos were frozen rather than transferred fresh — all three of which happen more often in PCOS than in the general IVF population, for reasons covered below.

Do People With PCOS Actually Get a Higher IVF Success Rate?

Not consistently, and the two largest comparisons available point in opposite directions by a few percentage points — which is itself the honest answer. A retrospective analysis of the US Society for Assisted Reproductive Technology (SART) registry, covering 42,286 IVF cycles in women with PCOS and women with tubal factor infertility, found PCOS patients retrieved more oocytes on average (16.4 vs. 12.8) and had a higher live birth rate per cycle (34.8% vs. 29.1%, odds ratio 1.30, 95% CI 1.24–1.35) across ages 20 to 44 (Kalra et al., 2013). A separate prospective cohort of 290 women under 37 having their first IVF cycle found close to the reverse — live birth per cycle of 37% in PCOS versus 40% in women with normal ovarian morphology, a difference the study did not report as statistically significant (Swanton et al., 2010). Read together, these are not a contradiction to resolve in one direction — they are what “broadly comparable, not dramatically different” looks like across two real studies with two different populations, cycle-year ranges, and clinical protocols. Neither number is “the” PCOS IVF success rate, because no single number is.

How Much Can the Denominator Alone Change the Headline Number?

Enough to make the same patient population look nearly twice as successful on one denominator as on another. A single-center cohort of 263 women with PCOS aged 35 to 46 (mean 37), matched by age and BMI to 526 women with tubal factor infertility, reported three different “success rate” numbers for the same two groups over the same two-year window (Mai et al., 2021):

Table 2 — the same PCOS and control groups, three denominators (Mai et al. 2021, single-center retrospective cohort, China, women aged 35–46).
What’s being divided by whatPCOS group (n=263)Age/BMI-matched controls (n=526)
Live births per fresh embryo transfer44.4%23.9%
Live births per frozen embryo transfer31.4%20.8%
Cumulative live births per patient, 2 years, any transfer55.5%38.0%

Every row in Table 2 describes the same two cohorts. The per-fresh-transfer number makes PCOS look nearly double the control rate; the cumulative number — the fairer summary, because it counts every attempt a patient actually had, not just her first — narrows that gap to about 17 percentage points. Neither number is fabricated, and neither is “the” rate. This is one center’s data, not a national registry, and it should be read as an illustration of how much the choice of denominator alone can move a headline figure — not as a generalizable PCOS success rate on its own.

The US national registry data available follows the same pattern in outline. The same SART-based analysis that found a 34.8%-versus-29.1% per-cycle gap also found that gap narrowed to nothing by age 40: implantation, clinical pregnancy, miscarriage, and live birth rates were not significantly different between PCOS and tubal-factor patients for each year of age past 40 (Kalra et al., 2013) — despite PCOS patients continuing to retrieve more oocytes at every age. More eggs at 42 did not buy a higher live birth rate at 42.

Why Would a Clinic Deliberately Not Try to Retrieve the Maximum Number of Eggs?

Because PCOS is the single biggest risk factor for ovarian hyperstimulation syndrome (OHSS), and two protocol choices with randomized trial evidence behind them trade a small amount of egg yield for a meaningfully lower OHSS rate. Freezing every embryo instead of transferring one fresh, in the largest PCOS-specific randomized trial available, cut OHSS from 7.1% to 1.3% in 1,508 women with PCOS, at the cost of a rise in preeclampsia among the frozen-transfer group, from 1.4% to 4.4% (Chen et al., 2016). Switching the final trigger injection from hCG to a GnRH agonist lowered moderate-to-severe OHSS from an estimated 5% to between 0% and 2% in a pooled analysis of 8 trials and 989 women — but only in fresh-transfer cycles, where live birth fell substantially alongside it; that trade-off disappeared in donor-egg and freeze-all cycles, where no fresh pregnancy lands on the already-stimulated ovary in the same cycle (Youssef et al., 2014).

Which Denominator Should You Actually Ask Your Clinic For?

All three, because each answers a different question and a single number cannot answer all of them. “Per cycle started” tells you the odds looking forward from the day stimulation begins, including the chance a cycle is cancelled before retrieval for an over-response. “Per retrieval” or “per transfer” tells you the odds conditional on having already reached that stage — a higher number by definition, because it has already excluded the cycles that did not get that far. “Cumulative,” counted across every transfer from one stimulation and retrieval, is the number that most closely answers “what are my odds of a baby from this one round of stimulation” — and it is the number Table 2 shows moving the least dramatically between PCOS and non-PCOS patients, because it is the hardest one to inflate by counting a narrower slice of the process.

Table 3 — what each denominator does and does not include.
DenominatorWhat’s excluded from the countTends to run
Per cycle startedNothing — includes cycles cancelled before retrievalLowest
Per retrieval / per transferCancelled cycles and cycles with no embryo to transferMiddle
Cumulative, per patient, all transfersNothing after retrieval — every frozen transfer countsHighest, but fairest

Cancellation before retrieval happens more often in PCOS specifically, which is part of why a per-cycle-started number and a per-retrieval number diverge further for PCOS patients than for the general IVF population — a high-responding ovary is more often the reason a cycle is cancelled or converted to a freeze-all in the first place, for the same OHSS-avoidance reasons covered above. A clinic quoting only a per-transfer number is not lying; it is answering a narrower question than the one most people are actually asking.

You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 organizations renamed it. Every figure on this page applies under either name — this article uses PCOS because that is still what most readers search.

Who These Numbers Do Not Describe

None of the studies above sorted patients by PCOS phenotype, and the 2023 international PCOS guideline is explicit that fertility treatment decisions — including which trigger, and whether to freeze all embryos — are made individually between a patient and her treating clinic, using antral follicle count, AMH, and real-time hormone data this page does not have (Teede et al., 2023). A registry average also cannot describe age past the top of its own bands, a specific sperm-quality factor, or a prior cycle’s actual retrieval and fertilization numbers — all of which move an individual result away from any population figure on this page. A high or low success-rate number also says nothing about whether the embryos behind it are more or less likely to be chromosomally normal — a separate question with its own evidence base, not answered by any registry percentage on this page. If a large retrieval number or a specific quoted rate is the reason you are here, this site’s PCOS egg retrieval numbers page covers what a retrieval count itself does and does not predict, and the freeze-all decision specifically has its own dedicated comparison. For the separate question of whether age changes PCOS fertility outside of an IVF cycle specifically, PCOS fertility after 35 covers that. For ovulation induction, IUI, and the other decision points that come before IVF is even on the table, PCOSguides’ fertility section starts from the beginning.

Common questions

  • What is the IVF success rate for PCOS by age?

    There is no single number — a 2021 UK national report found birth rates per embryo transferred ranging from 33% at ages 18-34 to 4% at ages 43-50 in the general IVF population, while PCOS-specific studies show live birth rates within a few points of non-PCOS rates once the same denominator is used.
  • Do people with PCOS have higher IVF success rates than everyone else?

    Not reliably. A 2013 SART registry analysis found a higher per-cycle live birth rate in PCOS (34.8% vs. 29.1%), while a separate 290-woman cohort found a slightly lower one (37% vs. 40%, not statistically significant) - the two largest comparisons point in different directions by a few points.
  • Why do IVF success rate numbers vary so much between sources?

    Because 'success rate' can mean per cycle started, per egg retrieval, per embryo transferred, or cumulative across every transfer from one retrieval. One cohort study found the same PCOS and control groups showing rates of 44.4% and 55.5% depending on which denominator was used.
  • Does PCOS success rate drop the same way with age as everyone else's?

    Largely yes in absolute pattern, but the PCOS-versus-control gap narrows with age - a SART-based study found no significant PCOS-versus-tubal-factor difference in live birth rate for each year of age past 40, despite PCOS patients still retrieving more oocytes at that age.
  • Why would a fertility clinic freeze all embryos instead of transferring one fresh?

    To lower ovarian hyperstimulation syndrome (OHSS) risk, which is highest in PCOS. The largest PCOS-specific randomized trial found freeze-all cut OHSS from 7.1% to 1.3%, at the cost of a rise in preeclampsia in the frozen-transfer group.
  • Which IVF success rate number should I actually ask my clinic for?

    Ask for all three: per cycle started (includes cancelled cycles), per retrieval or transfer (excludes cancellations), and cumulative across every transfer from one retrieval. Cumulative is generally the fairest single number because it is hardest to inflate by counting a narrower slice of the process.

More on this

Sources

  1. 1.Kalra SK, Ratcliffe SJ, Dokras A. Is the Fertile Window Extended in Women With Polycystic Ovary Syndrome? Utilizing the SART Registry to Assess the Impact of Reproductive Aging on Live-Birth Rate. Fertil Steril. 2013.
  2. 2.Mai Z, Liu M, Pan P, Li L, Huang J, Chen X, Yang D. Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles. Front Endocrinol. 2021.
  3. 3.Human Fertilisation and Embryology Authority. Fertility Treatment 2021: Preliminary Trends and Figures. HFEA. 2023.
  4. 4.Tang K, Wu L, Luo Y, Gong B. In Vitro Fertilization Outcomes in Women With Polycystic Ovary Syndrome: A Meta-Analysis. Eur J Obstet Gynecol Reprod Biol. 2021.
  5. 5.Swanton A, Story L, McVeigh E, Child T. IVF Outcome in Women With PCOS, PCO and Normal Ovarian Morphology. Eur J Obstet Gynecol Reprod Biol. 2010.
  6. 6.Chen ZJ, Shi Y, Sun Y, et al. Fresh Versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome. N Engl J Med. 2016.
  7. 7.Youssef MA, Van der Veen F, Al-Inany HG, et al. Gonadotropin-Releasing Hormone Agonist Versus HCG for Oocyte Triggering in Antagonist-Assisted Reproductive Technology. Cochrane Database Syst Rev. 2014.
  8. 8.Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023.
  9. 9.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine Metabolic Ovarian Syndrome, the New Name for Polycystic Ovary Syndrome: A Multistep Global Consensus Process. Lancet. 2026.

Find your PCOS type

Loading the questions…